The Aspirin Debate: Does Preventive Use Truly Reduce Mortality Risks?

Aspirin, often regarded as a wonder drug, has been widely recommended for the prevention of cardiovascular disease (CVD). However, its effectiveness in reducing mortality risks is now being reevaluated. A recent study titled "Low- or High-Dose Preventive Aspirin Use and Risk of Death from All Causes, Cardiovascular Disease, and Cancer" investigates whether aspirin taken at different doses affects the risk of death from all causes, CVD, or cancer.

The findings present a complex and somewhat concerning picture: low-dose aspirin shows no significant protective benefits, while high-dose aspirin may actually increase the risk of death due to CVD, especially among older adults. This post delves into these findings, highlighting the implications of aspirin's use for preventive health.

Functional Medicine, General HealthScott Solomons, DDSSeptember 29, 2025Cardiovascular Disease Prevention, Cancer Mortality, All-Cause Mortality, Preventive Medicine, Aspirin Risks, Public Health, Age and Aspirin Efficacy, Aspirin UseComment